Biogen Overview
Biogen Target Price
Analysts' 12-month price predictions for BIIB.
Share Price
$131.86
Average Target Price
$195.71
48.4% upside
48.4% upside7 analysts in the last 4 months
High: $270 | Low: $118
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-05 | H.C. WainwrightAndrew Fein | $187 | 41.8% upside |  |
| 2025-05-02 | OppenheimerJay Olson | $205 | 55.5% upside | |
| 2025-04-28 | HSBC | $118 |  10.5% downside | |
| 2025-02-13 | Canaccord GenuitySumant Kulkarni | $265 | 101% upside | |
| 2025-02-12 | CitigroupGeoff Meacham | $160 | 21.3% upside | |
| 2025-02-12 | Wells FargoMohit Bansal | $165 | 25.1% upside | |
| 2025-02-12 | NeedhamAmi Fadia | $270 | 104.8% upside | |
| 2024-12-09 | JefferiesMichael Yee | $180 | 36.5% upside | |
| 2024-11-15 | Robert W. BairdBrian Skorney | $300 | 127.5% upside | |
| 2024-10-31 | Morgan StanleyTerence Flynn | $204 | 54.7% upside | |
| 2024-10-31 | OppenheimerJay Olson | $255 | 93.4% upside | |
| 2024-10-30 | Raymond JamesChristopher Raymond | $315 | 138.9% upside | |
| 2024-10-30 | Goldman SachsSalveen Richter | $290 | 119.9% upside | |
| 2024-10-17 | BMO CapitalEvan Seigerman | $230 | 74.4% upside | |
| 2024-10-03 | UBSAshwani Verma | $202 | 53.2% upside | |
| 2024-09-23 | WedbushLaura Chico | $205 | 55.5% upside | |
| 2024-07-29 | Robert W. BairdBrian Skorney | $294 | 123% upside | |
| 2024-07-26 | Goldman SachsSalveen Richter | $342 | 159.4% upside | |
| 2024-07-26 | Piper SandlerChristopher Raymond | $307 | 132.8% upside | |
| 2024-07-26 | RBC CapitalBrian Abrahams | $282 | 113.9% upside | |
| 2024-07-12 | Piper SandlerChristopher Raymond | $313 | 137.4% upside | |
| 2024-07-11 | Morgan StanleyTerence Flynn | $311 | 135.9% upside | |
| 2024-06-12 | ScotiabankGeorge Farmer | $275 | 108.6% upside | |
| 2024-05-23 | BMO CapitalEvan David Seigerman | $260 | 97.2% upside | |
| 2024-05-22 | Morgan StanleyMatthew Harrison | $331 | 151% upside | |
| 2024-05-22 | Stifel NicolausPaul Matteis | $275 | 108.6% upside | |
| 2024-05-22 | Raymond JamesChristopher Raymond | $335 | 154.1% upside | |
| 2024-04-25 | H.C. WainwrightAndrew Fein | $300 | 127.5% upside | |
| 2024-04-25 | WedbushLaura Chico | $215 | 63.1% upside | |
| 2024-04-25 | RBC CapitalBrian Abrahams | $317 | 140.4% upside | |
| 2024-04-19 | OppenheimerJay Olson | $270 | 104.8% upside | |
| 2024-04-03 | BarclaysCarter Gould | $215 | 63.1% upside | |
| 2023-08-07 | WedbushLaura Chico | $269 | 104% upside | |
| 2023-05-01 | GuggenheimYatin Suneja | $350 | 165.4% upside | |
| 2022-12-01 | Atlantic Equities | $295 | 123.7% upside | |
| 2022-11-30 | Barclays | $313 | 137.4% upside | |
| 2022-11-30 | Jefferies | $350 | 165.4% upside | |
| 2022-11-30 | Wedbush | $247 | 87.3% upside | |
| 2022-11-15 | Truist Financial | $350 | 165.4% upside | |
| 2022-11-11 | Guggenheim | $270 | 104.8% upside | |
| 2022-09-30 | J.P. Morgan | $275 | 108.6% upside | |
| 2022-09-28 | Atlantic EquitiesSteve Chesney | $200 | 51.7% upside | |
| 2022-09-28 | RBC Capital | $321 | 143.4% upside | |
| 2022-09-28 | Morgan StanleyMatthew Harrison | $285 | 116.1% upside | |
| 2022-09-28 | NeedhamAmi Fadia | $250 | 89.6% upside | |
| 2022-09-28 | Wedbush | $217 | 64.6% upside | |
| 2022-09-28 | Wells Fargo | $350 | 165.4% upside | |
| 2022-09-28 | Piper Sandler | $280 | 112.3% upside | |
| 2022-09-28 | BMO CapitalEvan David Seigerman | $360 | 173% upside | |
| 2022-09-28 | Mizuho SecuritiesSalim Syed | $270 | 104.8% upside | |